Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. ADVISORY SERVICES AGREEMENTAdvisory Services Agreement • August 10th, 2023 • Oncternal Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 10th, 2023 Company Industry JurisdictionThis Advisory Services Agreement (this “Agreement”) is effective June 14, 2023 (the “Effective Date”) by and between Oncternal Therapeutics, Inc., a Delaware corporation (“Oncternal”) and Gunnar F. Kaufmann, Ph.D. (“Advisor”), to state the terms under which Advisor shall perform services for Oncternal.